Display options
Cite
Abubakar M, Guo C, Koka H, et al. Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression. NPJ Breast Cancer. 2019;5:20doi: 10.1038/s41523-019-0117-7.
Abubakar, M., Guo, C., Koka, H., Sung, H., Shao, N., Guida, J., Deng, J., Li, M., Hu, N., Zhou, B., Lu, N., & Yang, X. R. (2019). Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression. NPJ breast cancer, 520. https://doi.org/10.1038/s41523-019-0117-7
Abubakar, Mustapha, et al. "Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression." NPJ breast cancer vol. 5 (2019): 20. doi: https://doi.org/10.1038/s41523-019-0117-7
Abubakar M, Guo C, Koka H, Sung H, Shao N, Guida J, Deng J, Li M, Hu N, Zhou B, Lu N, Yang XR. Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression. NPJ Breast Cancer. 2019 Jul 25;5:20. doi: 10.1038/s41523-019-0117-7. eCollection 2019. PMID: 31372496; PMCID: PMC6658470.
Copy Download .nbib Format: NLM
Share it on

NPJ Breast Cancer. 2019 Jul 25;5:20. doi: 10.1038/s41523-019-0117-7. eCollection 2019.

Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression.

NPJ breast cancer

Mustapha Abubakar, Changyuan Guo, Hela Koka, Hyuna Sung, Nan Shao, Jennifer Guida, Joseph Deng, Mengjie Li, Nan Hu, Bin Zhou, Ning Lu, Xiaohong R Yang

Affiliations

  1. 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892 USA.
  2. 2National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021 Beijing, China.
  3. 3Surveillance and Health Services Research, American Cancer Society, Atlanta, GA 30303 USA.
  4. 4Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Sun Yat-sen University, 510275 Guangzhou, China.
  5. 5Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892 USA.
  6. 6Vanderbilt University, Nashville, TN 37235 USA.

PMID: 31372496 PMCID: PMC6658470 DOI: 10.1038/s41523-019-0117-7

[No abstract available.]

Keywords: Breast cancer; Cancer epidemiology; Prognostic markers

Conflict of interest statement

Competing interestsThe authors declare no competing interests.

References

  1. Adv Cancer Res. 2000;77:81-137 - PubMed
  2. Nature. 2000 Aug 17;406(6797):747-52 - PubMed
  3. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 - PubMed
  4. Arch Pathol Lab Med. 2002 Apr;126(4):456-8 - PubMed
  5. Hum Mutat. 2003 Mar;21(3):292-300 - PubMed
  6. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23 - PubMed
  7. Cancer Causes Control. 2003 Sep;14(7):609-18 - PubMed
  8. Breast Cancer Res. 2006;8(4):R43 - PubMed
  9. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):439-43 - PubMed
  10. Mol Cell Biol. 2008 Jul;28(13):4365-76 - PubMed
  11. J Clin Oncol. 2009 Mar 10;27(8):1160-7 - PubMed
  12. J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):87-98 - PubMed
  13. J Natl Cancer Inst. 2009 May 20;101(10):736-50 - PubMed
  14. Int J Cancer. 2009 Oct 15;125(8):1926-34 - PubMed
  15. Breast Cancer Res Treat. 2010 Jun;121(3):777-88 - PubMed
  16. Cold Spring Harb Perspect Biol. 2010 Dec;2(12):a000893 - PubMed
  17. PLoS Med. 2010 May 25;7(5):e1000279 - PubMed
  18. Cancer. 2010 Nov 1;116(21):4933-43 - PubMed
  19. Cancer Causes Control. 2011 Mar;22(3):399-405 - PubMed
  20. J Natl Cancer Inst. 2011 Feb 2;103(3):250-63 - PubMed
  21. Clin Cancer Res. 2011 Aug 1;17(15):5170-8 - PubMed
  22. Genes Cancer. 2011 Apr;2(4):503-16 - PubMed
  23. Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1883-91 - PubMed
  24. Cancer Discov. 2012 Jun;2(6):503-11 - PubMed
  25. Int J Cancer. 2013 Mar 1;132(5):1227-31 - PubMed
  26. Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1848-55 - PubMed
  27. Curr Opin Obstet Gynecol. 2013 Feb;25(1):49-54 - PubMed
  28. EMBO J. 2013 Mar 6;32(5):617-28 - PubMed
  29. Int J Clin Oncol. 2014;19(3):467-72 - PubMed
  30. Sci Rep. 2013;3:2246 - PubMed
  31. Nat Rev Clin Oncol. 2013 Sep;10(9):494-506 - PubMed
  32. Ann Oncol. 2013 Sep;24(9):2206-23 - PubMed
  33. Anticancer Res. 2013 Sep;33(9):3891-7 - PubMed
  34. Breast. 2013 Aug;22 Suppl 2:S27-9 - PubMed
  35. Breast Cancer Res Treat. 2013 Oct;141(3):409-20 - PubMed
  36. J Breast Cancer. 2013 Dec;16(4):386-94 - PubMed
  37. Breast Cancer Res Treat. 2014 Feb;144(1):1-10 - PubMed
  38. Clin Cancer Res. 2014 Jul 1;20(13):3569-80 - PubMed
  39. Int J Clin Oncol. 2015 Apr;20(2):317-23 - PubMed
  40. Int J Cancer. 2014 Aug 1;135(3):669-81 - PubMed
  41. Nat Genet. 2014 Oct;46(10):1051-9 - PubMed
  42. Genome Biol. 2014 Aug 28;15(8):431 - PubMed
  43. Ann Oncol. 2015 Aug;26(8):1533-46 - PubMed
  44. PLoS One. 2015 Aug 04;10(8):e0124658 - PubMed
  45. Ann Oncol. 2015 Sep;26 Suppl 5:v8-30 - PubMed
  46. Breast Cancer Res Treat. 2015 Oct;153(3):477-91 - PubMed
  47. Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1297-304 - PubMed
  48. Breast Cancer Res. 2016 Jul 07;18(1):74 - PubMed
  49. Breast Cancer Res. 2016 Oct 18;18(1):104 - PubMed
  50. Int J Epidemiol. 2017 Feb 1;46(1):86-95 - PubMed
  51. Ann Oncol. 2017 Aug 1;28(8):1700-1712 - PubMed
  52. Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):96-102 - PubMed
  53. Breast Cancer Res. 2018 Sep 18;20(1):114 - PubMed
  54. Am J Epidemiol. 1996 Nov 15;144(10):924-33 - PubMed

Publication Types